Captor Therapeutics SA
60Q
Company Profile
Business description
Captor Therapeutics SA is a biopharmaceutical company. It is focused on development of protein degradation drugs for cancer and autoimmune diseases, which have limited or no known treatment options.
Contact
ul. Dunska 11
Wroclaw54-427
POLT: +48 537869089
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
91
Stocks News & Analysis
stocks
ASX energy producers: Energy prices rise sharply as global tensions flare, but long-term view unchanged
Our view on the chaotic energy markets.
stocks
ASX retail share remains cheap despite weaker earnings
Weaker profit result drives cut to fair value yet shares remain undervalued.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,702.60 | 34.10 | 0.39% |
| CAC 40 | 7,769.31 | 77.24 | -0.98% |
| DAX 40 | 22,612.97 | 344.11 | -1.50% |
| Dow JONES (US) | 45,960.11 | 469.38 | -1.01% |
| FTSE 100 | 9,972.17 | 134.67 | -1.33% |
| HKSE | 25,023.25 | 166.82 | 0.67% |
| NASDAQ | 21,408.08 | 521.74 | -2.38% |
| Nikkei 225 | 53,581.81 | 21.84 | -0.04% |
| NZX 50 Index | 12,935.39 | 41.60 | -0.32% |
| S&P 500 | 6,477.16 | 114.74 | -1.74% |
| S&P/ASX 200 | 8,505.00 | 33.40 | 0.39% |
| SSE Composite Index | 3,915.67 | 26.58 | 0.68% |